Navigation Links
Pharmasset to Present at Susquehanna's Second Annual SIGnificant Investment Options in Healthcare Conference on Wednesday, March 5th
Date:2/27/2008

PRINCETON, N.J., Feb. 27 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) management will present at Susquehanna Financial Group's Second Annual SIGnificant Investment Options in Healthcare Conference being held March 4-5, 2008 at the W Hotel in New York, NY. Schaefer Price, Pharmasset's Chief Executive Officer, will provide an overview of the company on Wednesday, March 5, 2008 from 2:00 PM to 2:30 PM (ET) in the W Hotel's Sea/Ocean Room. In addition, Dr. Michelle Berrey, Pharmasset's Chief Medical Officer, and Dr. Michael Otto, Pharmasset's Chief Scientific Officer, will participate in a hepatitis C virus (HCV) therapeutic workshop, entitled "HCV: Polymerase Inhibitors" on Wednesday, March 5, 2008 from 9:15 AM to 10:15 AM (ET).

To access a simultaneous webcast of Mr. Price's overview of the company via the internet, log on to the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm. Please connect to the website at least ten minutes prior to the start of the presentation to ensure adequate time for a reliable connection and any software download that may be necessary for the webcast.

A replay of the webcast will be available on Pharmasset's website for thirty days following the conference. The investor presentation will be available for download in PDF format immediately following the presentation in the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm.

About Pharmasset

Pharmasset is a clinical-stage pharmaceutical co
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Pharmasset to Present at the UBS Global Life Sciences Conference on Monday, September 24th
3. Pharmasset Accesses up to $30 Million of Working Capital
4. Pharmasset to Present at Three Investor Conferences in November 2007
5. Pharmasset Appoints Michael Rogers as Chief Development Officer
6. Pharmasset Reports Fiscal Year End 2007 Financial Results
7. Pharmasset to Present at the BIO CEO & Investor Conference 2008 on Monday, February 11th
8. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
9. Avicena Group to Present at Noble Financial Conference
10. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
11. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 2015 People with a common form of ... and sometimes profound improvements in their hearing and understanding ... a new multicenter study led by specialists at NYU ... online ahead of print in the journal The Laryngoscope July ... in the United States implanted ...
(Date:7/28/2015)... , July 21, 2015 Research and ... of the "Biomedical Refrigerators and Freezers Market ... and Forecast 2014 - 2022" report to ... refrigerators and freezers market has been segmented based ... blood banks, and others. The others segment includes ...
(Date:7/28/2015)... , July 28, 2015  Kerastem Technologies announce that ... the U.S. FDA Center For Biologics Evaluation and Research ... conduct a clinical trial investigating the safety and feasibility ... and early male pattern baldness (androgenic alopecia). ... follows initial clinical work in Europe ...
(Date:7/28/2015)... , July 28, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... that it has granted to German life sciences ... development and commercialization of biotechnology (collectively, the "Optionee"), ... oral allogenic tumor vaccine technology (the "Technology"), including ... cancer which is ready to enter a Phase ...
Breaking Biology Technology:Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 3Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 2Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 3Kerastem Receives Conditional Approval from FDA for Alopecia Trial 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 3
... WOODLANDS, Texas , June 3 Lexicon Pharmaceuticals, ... discovering and developing breakthrough treatments for human disease, announced today that ... pharmaceutical research, will present at two investor conferences next week in ... Annual Needham Healthcare Conference on Wednesday, June 9, 2010 ...
... 3 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM), today ... newly created position of President and Chief Operating Officer. Dr. Glover ... for its operations and infrastructure, in particular the development and commercialization ... , ...
... CINCINNATI , June 3 Kendle (Nasdaq: ... (CRO), today announced it is ranked a top CRO to ... Kendle is the only CRO to be ranked consistently among ... years in the annual U.S. and European site surveys conducted ...
Cached Biology Technology:Lexicon to Present at Two Major Healthcare Investor Conferences 2Lexicon to Present at Two Major Healthcare Investor Conferences 3YM BioSciences appoints Dr. Nick Glover as President and Chief Operating Officer 2YM BioSciences appoints Dr. Nick Glover as President and Chief Operating Officer 3YM BioSciences appoints Dr. Nick Glover as President and Chief Operating Officer 4YM BioSciences appoints Dr. Nick Glover as President and Chief Operating Officer 5Kendle Rated a Top CRO to Work with for Fourth Consecutive Year 2Kendle Rated a Top CRO to Work with for Fourth Consecutive Year 3
(Date:7/21/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology from ... also the user using unique personal identifiers including ...
(Date:7/13/2015)... , July 13, 2015 Synaptics ... of human interface solutions, today announced sampling of ... and display driver integration (TDDI) product targeting smartphones ... first to combine Synaptics , best-in-class touch ... display driver technology developed in the company,s Japan ...
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
... The American Physiological Society (APS; www.the-APS.org ) announced ... Fellowships to TanYa Gwathmey and Kesia Mathis. This is ... Gwathmey, an African-American, is a postdoctoral fellow in the ... University School of Medicine in Winston-Salem, N.C. There she ...
... previously-unreported callus hairs growing in the flesh of mature ... storage implications for commercial growers. To find out ... Mary Parker of the Institute of Food Research. Apples ... history and Fuji apples are particularly prized for their ...
... the launch of Bioscience Horizons, a unique peer-reviewed journal ... in the UK and Republic of Ireland. ... a collaboration between the universities of Leeds, Nottingham, Reading, ... to provide a forum for the brightest undergraduates in ...
Cached Biology News:APS names 2 minority outreach fellows 2APS names 2 minority outreach fellows 3Popular apple variety harbors unusual cell growth 2
The BD PhosFlow Fix Buffer I can be used for the simultaneous fixation and permeabilization of cells prior to intracellular staining. Applications: Intracellular Staining (Flow) Storage Temperature:...
Request Info...
Raised to 5-HIAA coupled to BSA with paraformaldehyde....
NuCycl DAPI Kit Application: Flow Cytometry Reactivity: Human...
Biology Products: